Published in Proc Natl Acad Sci U S A on May 14, 2007
Role of Porphyromonas gingivalis SerB in gingival epithelial cell cytoskeletal remodeling and cytokine production. Infect Immun (2008) 1.21
Beta-actin association with endothelial nitric-oxide synthase modulates nitric oxide and superoxide generation from the enzyme. J Biol Chem (2009) 0.95
Simulated microgravity perturbs actin polymerization to promote nitric oxide-associated migration in human immortalized Eahy926 cells. Protoplasma (2010) 0.91
Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase. Br J Pharmacol (2009) 0.88
Insulin, insulin resistance, and platelet signaling in diabetes. Diabetes Care (2009) 0.82
Platelet redox balance in diabetic patients with hypertension improved by n-3 fatty acids. Diabetes Care (2012) 0.78
Genome wide expression analysis suggests perturbation of vascular homeostasis during high altitude pulmonary edema. PLoS One (2014) 0.77
Bidirectional cross-regulation between the endothelial nitric oxide synthase and β-catenin signalling pathways. Cardiovasc Res (2014) 0.75
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Effects of cytochalasin and phalloidin on actin. J Cell Biol (1987) 10.32
Endothelium-derived relaxing and contracting factors. FASEB J (1989) 7.22
Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature (1998) 4.65
Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet (1987) 4.55
Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell (1995) 4.39
Application of cryoultramicrotomy to immunocytochemistry. J Microsc (1986) 3.95
Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol (2003) 3.44
Mechanisms of actin rearrangements mediating platelet activation. J Cell Biol (1992) 3.28
Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell (1995) 3.08
Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res (1996) 2.43
Cytoskeleton of human platelets at rest and after spreading. J Cell Biol (1980) 1.96
Disruption of Golgi structure and function in mammalian cells expressing a mutant dynamin. J Cell Sci (2000) 1.95
Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol (1999) 1.85
Transformation and motility of human platelets: details of the shape change and release reaction observed by optical and electron microscopy. J Cell Biol (1979) 1.73
Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90. Antimicrob Agents Chemother (2003) 1.44
Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release. J Biol Chem (2000) 1.31
NOSIP, a novel modulator of endothelial nitric oxide synthase activity. FASEB J (2001) 1.29
Regulation of endothelial nitric oxide synthase by the actin cytoskeleton. Am J Physiol Cell Physiol (2003) 1.25
The biological and pharmacological role of nitric oxide in platelet function. Adv Exp Med Biol (1993) 1.20
Polymerization and organization of actin filaments within platelets. Semin Hematol (1983) 1.16
Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Commun (1993) 1.15
Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol (1997) 1.13
Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J (2003) 1.12
Protein kinases as mediators of fluid shear stress stimulated signal transduction in endothelial cells: a hypothesis for calcium-dependent and calcium-independent events activated by flow. J Biomech (1995) 1.03
Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev (2003) 1.03
VASP protects actin filaments from gelsolin: an in vitro study with implications for platelet actin reorganizations. Cell Motil Cytoskeleton (2000) 1.02
The proline-rich domain of dynamin-2 is responsible for dynamin-dependent in vitro potentiation of endothelial nitric-oxide synthase activity via selective effects on reductase domain function. J Biol Chem (2002) 0.99
2E4 (kaptin): a novel actin-associated protein from human blood platelets found in lamellipodia and the tips of the stereocilia of the inner ear. Eur J Cell Biol (1999) 0.97
Cytoskeletal domains in the activated platelet. Cell Motil Cytoskeleton (1995) 0.96
Organization of the actin cytoskeleton of resting and activated platelets in suspension. Am J Pathol (1986) 0.96
beta(2)-adrenoceptors activate nitric oxide synthase in human platelets. Circ Res (2000) 0.94
Antifungal antibodies: a new approach to the treatment of systemic candidiasis. Curr Opin Investig Drugs (2001) 0.86
Nitric oxide release from resting human platelets. Thromb Res (1995) 0.85
Aspirin modifies nitric oxide synthase activity in platelets: effects of acute versus chronic aspirin treatment. Cardiovasc Res (2003) 0.85
Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus. Diabetologia (2003) 0.80
Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA). Cell Biol Int (1998) 0.77
Freshwater biodiversity: importance, threats, status and conservation challenges. Biol Rev Camb Philos Soc (2005) 12.75
Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature (2002) 7.53
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64
A simple two-stage "bailout" technique for the removal of an unyielding ureteric stent. Urology (2013) 3.23
Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell (2013) 3.10
Identification of an intestinal heme transporter. Cell (2005) 3.05
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A (2005) 2.55
Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol (2006) 2.50
A role of matrix metalloproteinase-8 in atherosclerosis. Circ Res (2009) 1.72
Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease. Hum Mol Genet (2010) 1.71
Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem (2007) 1.68
Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. Blood (2008) 1.61
Protein kinase CK2 contributes to the organization of sodium channels in axonal membranes by regulating their interactions with ankyrin G. J Cell Biol (2008) 1.60
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res (2007) 1.59
In vivo assessment of intraplaque and endothelial fibrin in ApoE(-/-) mice by molecular MRI. Atherosclerosis (2012) 1.56
Poor prescribing is continual. BMJ (2006) 1.55
Cardiac effects of amiloride and of enalapril in the spontaneously hypertensive rat. J Hypertens (2003) 1.41
Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. J Neurosci (2005) 1.35
AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. Ann N Y Acad Sci (2009) 1.30
The lipid and non-lipid effects of statins. Pharmacol Ther (2003) 1.29
Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes Infect (2003) 1.28
Platelets interplay between pneumonia and cardiovascular events: establishing a link? J Am Coll Cardiol (2015) 1.28
Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PLoS One (2011) 1.24
V-ATPase membrane sector associates with synaptobrevin to modulate neurotransmitter release. Neuron (2010) 1.19
VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum Mol Genet (2011) 1.19
Pharmacogenetics of aspirin resistance: a comprehensive systematic review. Br J Clin Pharmacol (2008) 1.18
Noninvasive magnetic resonance imaging evaluation of endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent. Circulation (2012) 1.14
Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med (2011) 1.13
Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications. Clin Pharmacokinet (2012) 1.12
The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse y1 cell line. Endocrinology (2007) 1.12
Protein deiminases: new players in the developmentally regulated loss of neural regenerative ability. Dev Biol (2011) 1.12
Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J (2003) 1.12
Disruption of hexokinase II-mitochondrial binding blocks ischemic preconditioning and causes rapid cardiac necrosis. Circ Res (2011) 1.12
ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics (2004) 1.11
Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J (2008) 1.11
Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction. Circulation (2009) 1.08
Does vitamin D really contribute to excess cardiovascular risk in rheumatoid arthritis? Comment on the article by Haque et al. Arthritis Care Res (Hoboken) (2013) 1.07
Magnetic conjugated polymer nanoparticles as bimodal imaging agents. J Am Chem Soc (2010) 1.07
Platelet-derived nitric oxide signaling and regulation. Circ Res (2007) 1.06
The c-Abl tyrosine kinase phosphorylates the Fe65 adaptor protein to stimulate Fe65/amyloid precursor protein nuclear signaling. J Biol Chem (2004) 1.06
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Eur J Immunol (2004) 1.05
p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol Cell Neurosci (2004) 1.04
The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo. PLoS One (2009) 1.04
Mutations in genes encoding the glycine cleavage system predispose to neural tube defects in mice and humans. Hum Mol Genet (2011) 1.03
Nitric oxide signalling in the regulation of cardiovascular and platelet function. Front Biosci (Landmark Ed) (2011) 1.02
Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice. Proteomics (2004) 1.02
A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis (2005) 1.02
CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function. Eur J Immunol (2013) 1.01
Epileptic and developmental disorders of the speech cortex: ligand/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR. Hum Mol Genet (2008) 1.00
Fibronectin type III-like domains of neurofascin-186 protein mediate gliomedin binding and its clustering at the developing nodes of Ranvier. J Biol Chem (2011) 0.99
A reevaluation of the roles of hexokinase I and II in the heart. Am J Physiol Heart Circ Physiol (2006) 0.99
Plasma transthyretin as a candidate marker for Alzheimer's disease. J Alzheimers Dis (2012) 0.99
Plasma based markers of [11C] PiB-PET brain amyloid burden. PLoS One (2012) 0.98
Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt. Br J Pharmacol (2004) 0.97
Ca2+/calmodulin transfers the membrane-proximal lipid-binding domain of the v-SNARE synaptobrevin from cis to trans bilayers. Proc Natl Acad Sci U S A (2004) 0.97
3D morphology of the human hepatic ferritin mineral core: new evidence for a subunit structure revealed by single particle analysis of HAADF-STEM images. J Struct Biol (2008) 0.95
Evaluation of absolute peptide quantitation strategies using selected reaction monitoring. Proteomics (2011) 0.95
Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension. J Hypertens (2009) 0.94
Neuronal low-density lipoprotein receptor-related protein 1 binds and endocytoses prion fibrils via receptor cluster 4. J Cell Sci (2010) 0.94
Calmodulin-dependent regulation of a lipid binding domain in the v-SNARE synaptobrevin and its role in vesicular fusion. Biol Cell (2003) 0.94
ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth. J Biol Chem (2005) 0.94
Daily changes in synaptic innervation of VIP neurons in the rat suprachiasmatic nucleus: contribution of glutamatergic afferents. Eur J Neurosci (2010) 0.93
Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization. PLoS One (2012) 0.93
Platelet activation in essential hypertension: implications for antiplatelet treatment. Am J Hypertens (2010) 0.92
Is there a transient rise in sub-sarcolemmal Na and activation of Na/K pump current following activation of I(Na) in ventricular myocardium? Cardiovasc Res (2003) 0.92
A genetic variant of apolipoprotein M increases susceptibility to coronary artery disease in a Chinese population. Clin Exp Pharmacol Physiol (2007) 0.92
Structural insights into the exquisite selectivity of neurexin/neuroligin synaptic interactions. EMBO J (2010) 0.92
Molecular characterisation of endogenous Vangl2/Vangl1 heteromeric protein complexes. PLoS One (2012) 0.92
X-ray microanalysis investigation of the changes in Na, K, and hemoglobin concentration in plasmodium falciparum-infected red blood cells. Biophys J (2011) 0.91
Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers. Expert Rev Proteomics (2007) 0.91
MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent. Circ Cardiovasc Imaging (2011) 0.91
Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. J Am Soc Nephrol (2003) 0.91
The genetics of aspirin resistance. Int J Clin Pract (2007) 0.90
Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension. Eur Heart J (2009) 0.90
Lamin b1 polymorphism influences morphology of the nuclear envelope, cell cycle progression, and risk of neural tube defects in mice. PLoS Genet (2012) 0.90
A profile of an endosymbiont-enriched fraction of the coral Stylophora pistillata reveals proteins relevant to microbial-host interactions. Mol Cell Proteomics (2012) 0.89
Noninvasive MRI monitoring of the effect of interventions on endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent. J Am Heart Assoc (2013) 0.89
Identification and functional characterization of cytoplasmic determinants of plasmid DNA nuclear import. J Biol Chem (2009) 0.89
Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes. Clin Exp Pharmacol Physiol (2009) 0.89
Proteomic characterisation of toxins isolated from nematocysts of the South Atlantic jellyfish Olindias sambaquiensis. Toxicon (2013) 0.89
Biophotonic techniques for the study of malaria-infected red blood cells. Med Biol Eng Comput (2010) 0.89
Pathophysiological consequences of TAT-HKII peptide administration are independent of impaired vascular function and ensuing ischemia. Circ Res (2013) 0.89
17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets. Clin Exp Pharmacol Physiol (2007) 0.88
Toxicity and endocytosis of spinocerebellar ataxia type 6 polyglutamine domains: role of myosin IIb. Traffic (2008) 0.88
Leiomyosarcoma of renal vein, initially resembling pheochromocytoma. Clin Exp Hypertens (2012) 0.88
Mechanisms underlying beta2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells. J Physiol (2006) 0.88
Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts. PLoS One (2013) 0.88
The role of dietary microparticles and calcium in apoptosis and interleukin-1beta release of intestinal macrophages. Gastroenterology (2002) 0.88
Long-term, large-scale biomonitoring of the unknown: assessing the effects of insecticides to control river blindness (onchocerciasis) in West Africa. Annu Rev Entomol (2004) 0.88
The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis. Br J Clin Pharmacol (2014) 0.88
Wnt3a induces exosome secretion from primary cultured rat microglia. BMC Neurosci (2012) 0.87
Use of a purified and functional recombinant calcium-channel beta4 subunit in surface-plasmon resonance studies. Biochem J (2002) 0.87
Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity. Cardiovasc Res (2009) 0.87
Pyridoxine inhibits endothelial NOS uncoupling induced by oxidized low-density lipoprotein via the PKCα signalling pathway in human umbilical vein endothelial cells. Br J Pharmacol (2012) 0.87
Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cell. Bioconjug Chem (2009) 0.87